Description
Glipmevia 50/850mg Tablets (30’s)
Glipmevia 50/850mg is a combination oral antidiabetic medication containing Glimepiride 50mg and Metformin Hydrochloride 850mg. It is formulated to effectively manage type 2 diabetes mellitus by combining two complementary actions to regulate blood glucose levels.
Key Features:
-
Glimepiride (50mg): Stimulates pancreatic beta cells to enhance insulin secretion.
-
Metformin (850mg): Decreases hepatic glucose production and improves peripheral insulin sensitivity.
-
Combination therapy provides superior glycemic control.
-
Supports blood sugar management alongside diet and exercise.
-
Typically administered once or twice daily with meals for optimal tolerance.
Indications:
-
Management of type 2 diabetes mellitus when lifestyle measures alone are insufficient.
-
Suitable for patients requiring combined sulfonylurea and metformin therapy.
Dosage & Administration:
-
Take with meals to minimize gastrointestinal side effects.
-
Dose individualized based on blood glucose levels and patient response.
-
Regular monitoring of blood glucose and renal function is recommended.
Precautions:
-
Not indicated for type 1 diabetes or diabetic ketoacidosis.
-
Use with caution in patients with liver or kidney impairment.
-
Patients should be informed about hypoglycemia and lactic acidosis symptoms.
-
Inform healthcare providers of all medications to avoid interactions.
Possible Side Effects:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal upset (nausea, diarrhea)
-
Weight gain
-
Rare allergic reactions
Storage:
-
Store in a cool, dry place below 25°C.
-
Keep out of reach of children.
Reviews
There are no reviews yet.